Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
1.180
+0.070 (6.31%)
At close: Oct 22, 2025, 4:00 PM EDT
1.190
+0.010 (0.85%)
After-hours: Oct 22, 2025, 7:59 PM EDT
Oncolytics Biotech Market Cap
Oncolytics Biotech has a market cap or net worth of $118.43 million as of October 22, 2025. Its market cap has increased by 39.75% in one year.
Market Cap
118.43M
Enterprise Value
108.35M
1-Year Change
39.75%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since October 5, 2001, Oncolytics Biotech's market cap has increased from $96.89M to $118.43M, an increase of 22.23%. That is a compound annual growth rate of 0.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 111.40M | 58.17% |
| Dec 31, 2024 | 70.43M | -28.92% |
| Dec 29, 2023 | 99.09M | 2.98% |
| Dec 30, 2022 | 96.22M | 25.79% |
| Dec 31, 2021 | 76.49M | -25.81% |
| Dec 31, 2020 | 103.10M | -17.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.80B |
| Johnson & Johnson | 462.11B |
| AbbVie | 408.76B |
| UnitedHealth Group | 330.91B |
| AstraZeneca | 259.08B |
| Novartis AG | 254.71B |
| Novo Nordisk | 245.28B |
| Abbott Laboratories | 221.98B |